Bioactive postbiotic production using metabolically active non-culturable GRAS bacteria

Overview

This technology leverages a novel biological state in which GRAS (Generally Recognized as Safe) bacteria remain metabolically active but cannot divide, enabling continuous production of beneficial bioactive compounds directly within food products. By inducing Lactococcus into this non-culturable state during fermentation, the platform delivers postbiotics—non-living microorganisms and their metabolites that confer health benefits—without introducing live, dividing bacteria into the final product.

The approach combines synthetic biology with a proprietary induction method to modulate bacterial metabolism and direct the production of specific compounds, including short-chain fatty acids and neuroactive metabolites derived from amino acids such as arginine, tryptophan, tyrosine, and phenylalanine. This offers food and beverage manufacturers a consistent, controllable means of incorporating health-promoting bioactives into dairy and plant-based products.

Technical specifications

Key features:

• Proprietary method for inducing Lactococcus into a metabolically active, non-culturable state during fermentation
• Synthetic biology tools to direct metabolic pathways toward desired bioactive compound production
• Production of established short-chain fatty acids with demonstrated bioactive properties
• Potential for neuroactive compound production from amino acid substrates (Arg, Trp, Tyr, Phe)
• Metabolic activity maintained for over 10 years in lab media without cell division
• Compatibility with both dairy (milk) and plant-based food matrices currently under validation
• GRAS-status organism that survives acid conditions and is easily genetically manipulated
• Continuous excretion of bioactive molecules directly into the food medium

Technology readiness level

The core hypothesis has been validated and reproduced across multiple experimental settings, with findings published in a series of peer-reviewed publications. Non-culturable Lactococcus cells producing bioactive short organic acids have been demonstrated in milk, and ongoing work is extending validation to plant-based media. Statistical and orthogonal analytical methods have confirmed the metabolic activity and bioactive output of these cells. The platform is positioned for pilot-scale demonstration and co-development with industry partners interested in functional food, dairy, and plant-based product innovation.